Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial
Journal of Neuroendocrinology · 2026-11 · 38 (11)
DOI: 10.1111/jne.70308 ↗Abstract
Abstract Prolactin (PRL) is involved in the modulation of sexual function. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have been proposed to modulate reward‐related processes beyond their effects on appetite, including sexual desire. In our previously published randomized parent trial of dulaglutide and sexual desire, we hypothesized that any potential effect on sexual desire could involve changes in PRL concentrations. Predefined secondary analysis of a single‐center randomized, double blind, placebo‐controlled, crossover trial involving 24 healthy eugonad men of normal weight (BMI 18.5–25 kg/m 2 or BMI 25.1–30 kg/m 2 and waist circumference
EUVIMED